Canada Names New Patented Medicine Prices Board Members

Health Canada

Today, the Honourable Marjorie Michel, Minister of Health, announced the appointment of Peter Moreland-Giraldeau as the new Vice-Chairperson and Conor McCourt as a member of the Board to the Patented Medicine Prices Review Board (PMPRB).

Mr. Moreland-Giraldeau is a lawyer by training with eight years of professional experience across multiple jurisdictions. He has served on the Board as a member since October 2023, and in his new position as Vice-Chairperson he will support the recently appointed Chairperson, Anie Perrault.

Mr. McCourt is a retired lawyer with extensive experience in the practice of pharmaceutical patent law and agency, health regulatory affairs, and pharmaceutical and biologics market access and pricing.

The PMPRB is an arm's-length organization of the government that protects the interests of Canadian consumers by ensuring that the prices of patented medicines sold in Canada are not excessive.

The Government of Canada is committed to appointing highly qualified candidates to best serve the interests of Canadians and to open, transparent, and merit-based processes for selecting Governor in Council appointees.

/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.